Cathie's Ark Logo
undefined Logo

ARKK Holdings of CRISPR Therapeutics (CRSP) - Updated Daily

TherapeuticsGene TherapyCAR-T Cell TherapyCRSPR Gene Editing
The Bucket Report Icon
Trader's Guide 2024Ships December 21st. Download our December Market Report and reserve your copy today.
Date
Direction
Shares
Fund Weight
Fund
November 1, 2023
BUY122.201k0.083%ARKK
October 17, 2023
BUY147.121k0.0963%ARKK
October 10, 2023
BUY7.796k0.005%ARKK
October 9, 2023
BUY81.413k0.0498%ARKK
June 21, 2023
BUY59.047k0.0401%ARKK

Key Statistics

⚖️Weighting🧢Market Cap
4.5%$5.16b
🏋🏿‍♂️Weight Rank In ARKK🌏Country
7🇨🇭Switzerland
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
7$62.32
🎫ARK Ownership Percent
6.79%

Other ETFs That Hold CRSP

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.7%
GNOMGlobal X Genomics & Biotechnology ETF3.52%
ARKKARK Innovation ETF3.37%
XBISPDR® S&P Biotech ETF1.01%
IBBiShares Biotechnology ETF0.35%
LABUS&P Biotech Bull 3X Shares ETF0.242%

Research Notes and Commentary for CRSP

No Research Notes Found for CRSP